PMID- 21212630 OWN - NLM STAT- MEDLINE DCOM- 20111021 LR - 20211020 IS - 1422-6421 (Electronic) IS - 1422-6405 (Print) IS - 1422-6405 (Linking) VI - 194 IP - 1 DP - 2011 TI - BMP-2 and TGFbeta2 shared pathways regulate endocardial cell transformation. PG - 1-12 LID - 10.1159/000322035 [doi] AB - Valvular heart disease is a major cause of mortality and morbidity. Revealing the cellular processes and molecules that regulate valve formation and remodeling is required to develop effective therapies. A key step in valve formation during heart development is the epithelial-mesenchymal transformation (EMT) of a subpopulation of endocardial cells in the atrioventricular cushion (AVC). The type III transforming growth factor-beta receptor (TGFbetaR3) regulates AVC endocardial cell EMT in vitro and mesenchymal cell differentiation in vivo. Little is known concerning the signaling mechanisms downstream of TGFbetaR3. Here we use endocardial cell EMT in vitro to determine the role of 2 well-characterized downstream TGFbeta signaling pathways in TGFbetaR3-dependent endocardial cell EMT. Targeting of Smad4, the common mediator Smad, demonstrated that Smad signaling is required for EMT in the AVC and TGFbetaR3-dependent EMT stimulated by TGFbeta2 or BMP-2. Although we show that Smads 1, 2, 3, and 5 are required for AVC EMT, overexpression of Smad1 or Smad3 is not sufficient to induce EMT. Consistent with the activation of the Par6/Smurf1 pathway downstream of TGFbetaR3, targeting ALK5, Par6, or Smurf1 significantly inhibited EMT in response to either TGFbeta2 or BMP-2. The requirement for ALK5 activity, Par6, and Smurf1 for TGFbetaR3-dependent endocardial cell EMT is consistent with the documented role of this pathway in the dissolution of tight junctions. Taken together, our data demonstrate that TGFbetaR3-dependent endocardial cell EMT stimulated by either TGFbeta2 or BMP-2 requires Smad4 and the activation of the Par6/Smurf1 pathway. CI - Copyright (c) 2011 S. Karger AG, Basel. FAU - Townsend, Todd A AU - Townsend TA AD - Department of Pharmacology, Vanderbilt University Medical Center, Nashville, Tenn., USA. FAU - Robinson, Jamille Y AU - Robinson JY FAU - Deig, Christopher R AU - Deig CR FAU - Hill, Cynthia R AU - Hill CR FAU - Misfeldt, Andrew AU - Misfeldt A FAU - Blobe, Gerard C AU - Blobe GC FAU - Barnett, Joey V AU - Barnett JV LA - eng GR - T32 GM007628/GM/NIGMS NIH HHS/United States GR - HL092551/HL/NHLBI NIH HHS/United States GR - GM062459/GM/NIGMS NIH HHS/United States GR - RL1 HL092551/HL/NHLBI NIH HHS/United States GR - GM007628/GM/NIGMS NIH HHS/United States GR - R25 GM062459/GM/NIGMS NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't DEP - 20110107 PL - Switzerland TA - Cells Tissues Organs JT - Cells, tissues, organs JID - 100883360 RN - 0 (Adaptor Proteins, Signal Transducing) RN - 0 (Bone Morphogenetic Protein 2) RN - 0 (Smad4 Protein) RN - 0 (TGFB3 protein, human) RN - 0 (Transforming Growth Factor beta2) RN - 0 (Transforming Growth Factor beta3) SB - IM MH - Adaptor Proteins, Signal Transducing/genetics/metabolism MH - Animals MH - Bone Morphogenetic Protein 2/*metabolism MH - Chick Embryo/metabolism MH - Endocardium/*cytology/metabolism MH - Humans MH - *Signal Transduction MH - Smad4 Protein/genetics/metabolism MH - Transfection MH - Transforming Growth Factor beta2/genetics/*metabolism MH - Transforming Growth Factor beta3/genetics/metabolism PMC - PMC3128155 EDAT- 2011/01/08 06:00 MHDA- 2011/10/22 06:00 PMCR- 2012/06/01 CRDT- 2011/01/08 06:00 PHST- 2010/10/14 00:00 [accepted] PHST- 2011/01/08 06:00 [entrez] PHST- 2011/01/08 06:00 [pubmed] PHST- 2011/10/22 06:00 [medline] PHST- 2012/06/01 00:00 [pmc-release] AID - 000322035 [pii] AID - cto0194-0001 [pii] AID - 10.1159/000322035 [doi] PST - ppublish SO - Cells Tissues Organs. 2011;194(1):1-12. doi: 10.1159/000322035. Epub 2011 Jan 7.